News 2021-04-21
2021 Pharmaceutical Crystallization Summit
Breaking Drug Development Bottlenecks via Enabling Technologies
Physical & chemical properties of drug substance (DS) have major impacts on the formulation process & Drug Product (DP) properties or quality attributes. The final step in an API synthesis is usually crystallization or precipitation, serving as both purification and isolation. This international conference gathers industrial and academic subject matter experts to discuss their works related to DS crystallization and manufacturing opportunities (highlighted below)for new drug development programs.
(1) crystal structure prediction, (2) crystal shape prediction, (3) solubility assessment, (4) purification, and (5) analytical technologies
(1) co-processed API’s, (2) process intensification, (3) additive manufacturing, (4) adv. process control & automation, (5)modular systems
Please Click the image below to see more details.
Others
More
News 2026-03-03
Porton Wins “2025 Best CRO” Award from Daewoong Pharma
Daewoong Pharma highly recognized Porton’s contributions to its drug development through active cooperation based on Porton’s excellent capabilities and expertise.

News 2026-02-03
Porton Newsletter - January 2026 Recap
Porton Newsletter - January 2026 Recap
